T Cell-Derived iPSCs as a Source of Regenerated T Cells: High Frequency Production of iPSC Clones Capable of Generating Potent Cytotoxic T Cells
Molecular Therapy - Methods and Clinical Development - United States
doi 10.1016/j.omtm.2019.12.006
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2020
Authors
Publisher
Elsevier BV